(Q33642739)

28 July 2017

1 reference

title

Vasculitic peripheral ulcerative keratitis (English)

1 reference

28 July 2017

Messmer EM

1

1 reference

28 July 2017

Foster CS

series ordinal

2

1 reference

28 July 2017

publication date

1 March 1999

1 reference

28 July 2017

published in

Survey of Ophthalmology

1 reference

28 July 2017

volume

43

1 reference

28 July 2017

issue

5

1 reference

28 July 2017

page(s)

379-396

1 reference

Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Churg-Strauss vasculitis presenting with severe visual loss due to bilateral sequential optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Decreased circulating thymus-derived cells with receptors for the Fc portion of immunoglobulin G in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Immunoglobulins in the Human Cornea

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Ocular lesions in relapsing polychondritis and other rheumatoid syndromes. The Edward Jackson memorial lecture.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Treatment of lupus nephritis: a meta-analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The management of corneal perforations associated with rheumatoid arthritis. An analysis of 32 eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Lamellar keratoplasty in the management of inflammatory corneal ulceration and perforation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Increased Antiretroviral Antibody Reactivity in Sera from a Defined Population of Patients with Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Early experience with intravenous immunoglobulin treatment in Wegener's granulomatosis with ocular involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Dramatic responses to intravenous immunoglobulin in vasculitis*

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

WEGENER'S GRANULOMATOSIS AND CORNEO-SCLERAL ULCER

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Ocular complications of Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Long-term treatment of systemic lupus erythematosus with cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Limited forms of angiitis and granulomatosis of Wegener's type

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Apoptosis and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Microscopic polyangiitis with ocular involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The concept of limited forms of Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Diagnosis and management of systemic Wegener's granulomatosis presenting with anterior ocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Multiple aortic aneurysms in relapsing polychondritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Necrotizing angiitis associated with drug abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

A Controlled Trial of Cyclophosphamide in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The arteritis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Allergic granulomatous angiitis associated with uveoscleritis and papilledema

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Relapsing polychondritis. Analytical literature review and studies on pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Relapsing polychondritis responding to colchicine

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Cyclophosphamide-induced remissions in advanced polyarteritis nodosa

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Conjunctival resection for the treatment of the rheumatoid corneal ulceration

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Tissue adhesive arrests stromal melting in the human cornea

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Antibodies to type II collagen in relapsing polychondritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Immunopathology of Scleritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

CENTRAL NERVOUS SYSTEM MANIFESTATIONS OF PERIARTERITIS NODOSA.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Immunosuppressive therapy for external ocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The histopathology of perilimbal ulceration in Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Long-term follow-up study of periarteritis nodosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Immune complexes in hepatitis B antigen-associated periarteritis nodosa. Detection by antibody-dependent cell-mediated cytotoxicity and the Raji cell assay

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Relapsing polychondritis with aortic arch aneurysm and aortic arch syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Association between polyarteritis and Australia antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Ocular findings in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Peripheral ulcerative keratitis in the collagen vascular diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Systemic necrotizing vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Anti-myeloperoxidase antibodies: Immunological characteristics and clinical associations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Peripheral ulcerative keratitis in the setting of rheumatoid arthritis: treatment with immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Scleral necrosis in periarteritis nodosa; a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Association between relapsing polychondritis and systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Histology and immunopathology of systemic lupus erythematosus affecting the conjunctiva

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Scleritis in relapsing polychondritis. Response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The Use of Alkylating Agents in the Treatment of Wegener's Granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Advances in immunotherapy of rheumatoid arthritis: clinical and immunological findings following treatment with anti-CD4 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Ocular and systemic findings in relapsing polychondritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Scleritis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Corneal autoimmunity in patients with peripheral ulcerative keratitis (PUK) in association with rheumatoid arthritis and Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Treatment of systemic and renal-limited vasculitic disorders with pooled human intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Anterior ischemic optic neuropathy in Churg-Strauss syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Decision-making in the therapy of external eye disease: noninfected corneal ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Polyarteritis nodosa complicated by bilateral optic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Retinopathy in systemic lupus erythematosus: relationship to disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Wegener's granulomatosis with destructive ocular manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Susceptibility to relapsing polychondritis is associated with HLA-DR4

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

New developments in the treatment of Wegener's granulomatosis, polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Immunosuppressive and corticosteroid therapy of polyarteritis nodosa

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

A HITHERTO UNDESCRIBED FORM OF VALVULAR AND MURAL ENDOCARDITIS

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Topical cyclosporine therapy for ulcerative keratitis associated with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Relapsing polychondritis and eye disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Hepatitis C virus infection and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Conjunctival inflammation and amyloidosis in allergic granulomatosis and angiitis (Churg-Strauss syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

'Pulsed' immunosuppressive therapy in the treatment of immunologically induced corneal and scleral disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Melting corneas with collapsing nose

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Distribution of hemolytic complement in the normal cornea

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Corneo-scleral ulceration in periarteritis nodosa

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Complement deficiency and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Retroviruses, apoptosis and autogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Overgrowth of human synovial cells driven by the human T cell leukemia virus type I tax gene

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Antineutrophil cytoplasmic antibodies in the classification of vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Results of penetrating keratoplasty for the treatment of corneal perforations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

New insights into the pathogenesis and treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Penetrating keratoplasty in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Relapsing polychondritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Corneal ulceration and perforation associated with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Review: Complement and Lupus: Old Concepts and New Directions

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Disease relapse in patients with ocular manifestations of Wegener granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Conjunctival lesions in periarteritis nodosa. A clinical and immunopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Tectonic keratoplasty for peripheral ulcerative keratitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

KERATOPATHY ASSOCIATED WITH SYSTEMIC LUPUS ERYTHEMATOSUS

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Treatment of Wegener's granulomatosis with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Peripheral corneal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Bcl-2 and Fas, molecules which influence apoptosis. A possible role in systemic lupus erythematosus?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Necrotizing scleritis after ocular surgery. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Emerging treatments for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Histological appearance of the synovium in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Systemic lupus erythematosus: sex hormones in male patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Disseminated lupus erythematosus; analysis of thirty-four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Conjunctival involvement in Churg-Strauss syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The antiquity of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The importance of C4A null genes in Norwegian patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Coagenase in corneal ulcerations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Immunology of systemic rheumatoid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Diagnostic Value of Anti-neutrophil Cytoplasmic Antibodies in Scleritis Associated with Wegener's Granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Corneal staining in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Lupus retinopathy. Patterns, associations, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Association of the B-cell alloantigen DRw4 with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Systemic lupus erythematosus: theories of pathogenesis and approach to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Ocular manifestations of diffuse collagen disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Ocular manifestations of Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Virus-like particles in synovial fluids from patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

[Recurrent polychondritis (von Meyenburg-Altherr-Uehlinger syndrome]

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Upregulated expression and function of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Characterization of in vivo mutated T cell clones from patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Ophthalmological and neuro-ophthalmological involvement in Churg-Strauss syndrome: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Management strategies in peripheral ulcerative keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Complement deficiency and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis)

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Vascular changes in peripheral corneal destructive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Scleritis and episcleritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Epidemiology of systemic vasculitis: changing incidence or definition?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The use of tissue adhesive in corneal perforations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Multisystem interactions in the pathogenesis of vasculitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The molecular basis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Mooren-type hepatitis C virus-associated corneal ulceration.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Ocular periarteritis nodosa; report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Autoantibodies to cartilage collagens in relapsing polychondritis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Topical treatment of severe corneal ulcers with cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Relapsing Polychondritis, Rheumatoid Arthritis and Blindness

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Peripheral Rheumatoid Ulceration and Evidence For Conjunctival Collagenase Production

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Systemic lupus erythematosus, discoid lupus erythematosus, and progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

Vasculitis with hepatitis B antigenemia: long-term observation in nine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0039-6257%2898%2900051-4

7 January 2021

10.1016/S0039-6257(98)00051-4

Identifiers

DOI

1 reference

28 July 2017

1 reference